Connect with us

News

Mars travelers can use ‘Star Trek’ Tricorder-like features using smartphone biotech: study

Published

on

Plans to take humans to the Moon and Mars come with numerous challenges, and the health of space travelers is no exception. One of the ways any ill-effects can be prevented or mitigated is by detecting relevant changes in the body and the body’s surroundings, something that biosensor technology is specifically designed to address on Earth. However, the small size and weight requirements for tech used in the limited habitats of astronauts has impeded its development to date.

A recent study of existing smartphone-based biosensors by scientists from Queen’s University Belfast (QUB) in the UK identified several candidates under current use or development that could be also used in a space or Martian environment. When combined, the technology could provide functionality reminiscent of the “Tricorder” devices used for medical assessments in the Star Trek television and movie franchises, providing on-site information about the health of human space travelers and biological risks present in their habitats.

Biosensors focus on studying biomarkers, i.e., the body’s response to environmental conditions. For example, changes in blood composition, elevations of certain molecules in urine, heart rate increases or decreases, and so forth, are all considered biomarkers. Health and fitness apps tracking general health biomarkers have become common in the marketplace with brands like FitBit leading the charge for overall wellness sensing by tracking sleep patterns, heart rate, and activity levels using wearable biosensors. Astronauts and other future space travelers could likely use this kind of tech for basic health monitoring, but there are other challenges that need to be addressed in a compact way.

The projected human health needs during spaceflight have been detailed by NASA on its Human Research Program website, more specifically so in its web-based Human Research Roadmap (HRR) where the agency has its scientific data published for public review. Several hazards of human spaceflight are identified, such as environmental and mental health concerns, and the QUB scientists used that information to organize their study. Their research produced a 20-page document reviewing the specific inner workings of the relevant devices found in their searches, complete with tables summarizing each device’s methods and suitability for use in space missions. Here are some of the highlights.

Advertisement
A chart showing the classification of scientific articles about relevant smartphone-based biosensors used in the Queen’s University Belfast study. | Credit: Biosensors/Queen’s University Belfast

Risks in the Spacecraft Environment

During spaceflight, the environment is a closed system that has a two-fold effect: One, the immune system has been shown to decrease its functionality in long-duration missions, specifically by lowering white blood cell counts, and two, the weightless and non-competitive environment make it easier for microbes to transfer between humans and their growth rates increase. In one space shuttle era study, the number of microbial cells in the vehicle able to reproduce increased by 300% within 12 days of being in orbit. Also, certain herpes viruses, such as those responsible for chickenpox and mononucleosis, have been reactivated under microgravity, although the astronauts typically didn’t show symptoms despite the presence of active viral shedding (the virus had surfaced and was able to spread).

Frequent monitoring of the spacecraft environment and the crew’s biomarkers is the best way to mitigate these challenges, and NASA is addressing these issues to an extent with traditional instruments and equipment to collect data, although often times the data cannot be processed until the experiments are returned to Earth. An attempt has also been made to rapidly quantify microorganisms aboard the International Space Station (ISS) via a handheld device called the Lab-on-a-Chip Application Development-Portable Test System (LOCAD-PTS). However, this device cannot distinguish between microorganism species yet, meaning it can’t tell the difference between pathogens and harmless species. The QUB study found several existing smartphone-based technologies generally developed for use in remote medical care facilities that could achieve better identification results.

NASA astronaut Karen Nyberg uses a fundoscope to image her eye while in orbit to study Visual Impairment Intracranial Pressure (VIIP) Syndrome. Smaller 3D printed retinal imaging adaptors for smartphones are being developed to perform the testing done by large devices similar to the instrument used here. | Credit: NASA

One of the devices described was a spectrometer (used to identify substances based on the light frequency emitted) which used the smartphone’s flashlight and camera to generate data that was at least as accurate as traditional instruments. Another was able to identify concentrations of an artificial growth hormone injected into cows called recominant bovine somatrotropin (rBST) in test samples, and other systems were able to accurately detect cyphilis and HIV as well as the zika, chikungunya, and dengue viruses. All of the devices used smartphone attachments, some of them with 3D-printed parts. Of course, the types of pathogens detected are not likely to be common in a closed space habitat, but the technology driving them could be modified to meet specific detection needs.

The Stress of Spaceflight

A group of people crammed together in a small space for long periods of time will be impacted by the situation despite any amount of careful selection or training due to the isolation and confinement. Declines in mood, cognition, morale, or interpersonal interaction can impact team functioning or transition into a sleep disorder. On Earth, these stress responses may seem common, or perhaps an expected part of being human, but missions in deep space and on Mars will be demanding and need fully alert, well-communicating teams to succeed. NASA already uses devices to monitor these risks while also addressing the stress factor by managing habitat lighting, crew movement and sleep amounts, and recommending astronauts keep journals to vent as needed. However, an all-encompassing tool may be needed for longer-duration space travels.

As recognized by the QUB study, several “mindfulness” and self-help apps already exist in the market and could be utilized to address the stress factor in future astronauts when combined with general health monitors. For example, the popular FitBit app and similar products collect data on sleep patterns, activity levels, and heart rates which could potentially be linked to other mental health apps that could recommend self-help programs using algorithms. The more recent “BeWell” app monitors physical activity, sleep patterns, and social interactions to analyze stress levels and recommend self-help treatments. Other apps use voice patterns and general phone communication data to assess stress levels such as “StressSense” and “MoodSense”.

A Tricorder-like setup is imagined by scientists at Queens University Belfast, utilizing the functionalities of existing smartphone-based biosensors. | Credit: Biosensors/Queens University Belfast

Advances in smartphone technology such as high resolution cameras, microphones, fast processing speed, wireless connectivity, and the ability to attach external devices provide tools that can be used for an expanding number of “portable lab” type functionalities. Unfortunately, though, despite the possibilities that these biosensors could mean for human spaceflight needs, there are notable limitations that would need to be overcome in some of the devices. In particular, any device utilizing antibodies or enzymes in its testing would risk the stability of its instruments thanks to radiation from galactic cosmic rays and solar particle events. Biosensor electronics might also be damaged by these things as well. Development of new types of shielding may be necessary to ensure their functionality outside of Earth and Earth orbit or, alternatively, synthetic biology could also be a source of testing elements genetically engineered to withstand the space and Martian environments.

The interest in smartphone-based solutions for space travelers has been garnering more attention over the years as tech-centric societies have moved in the “app” direction overall. NASA itself has hosted a “Space Apps Challenge” for the last 8 years, drawing thousands of participants to submit programs that interpret and visualize data for greater understanding of designated space and science topics. Some of the challenges could be directly relevant to the biosensor field. For example, in the 2018 event, contestants are asked to develop a sensor to be used by humans on Mars to observe and measure variables in their environments; in 2017, contestants created visualizations of potential radiation exposure during polar or near-polar flight.

Advertisement

While the QUB study implied that the combination of existing biosensor technology could be equivalent to a Tricorder, the direct development of such a device has been the subject of its own specific challenge. In 2012, the Qualcomm Tricorder XPRIZE competition was launched, asking competitors to develop a user-friendly device that could accurately diagnose 13 health conditions and capture 5 real-time health vital signs. The winner of the prize awarded in 2017 was Pennsylvania-based family team called Final Frontier Medical Devices, now Basil Leaf Technologies, for their DxtER device. According to their website, the sensors inside DxtER can be used independently, one of which is in a Phase 1 Clinical Trial. The second place winner of the competition used a smartphone app to connect its health testing modules and generate a diagnosis from the data acquired from the user.

The march continues to develop the technology humans will need to safely explore regions beyond Earth orbit. Space is hard, but it was hard before we went there the first time, and it was hard before we put humans on the moon. There may be plenty of challenges to overcome, but as the Queen’s University Belfast study demonstrates, we may already be solving them. It’s just a matter of realizing it and expanding on it.

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

News

Tesla looks keen to bring larger Model Y L to the U.S.

Published

on

Credit: Tesla

Tesla launched the slightly larger Model Y L in China last year, and it became a hit in no time. The longer wheelbase, larger interior, and slightly more forgiving legroom area in the Model Y L became a sought-after possibility for U.S. buyers, who have been begging the company for a larger SUV.

Now, Tesla needs it more than ever, especially considering the Model X was discontinued alongside its Model S sibling earlier this year. It looks to be more likely than ever, and based on recent reports, it will fall in line with CEO Elon Musk’s prediction that it would arrive in the United States in late 2026.

Recent reports from Forbes and Not a Tesla App both have indicated Tesla plans to bring the Model Y L to the U.S. this year. The reports cite “credible sources,” and an analyst from AutoForecast Solutions named Sam Fiorani stated that the car would enter production later this year.

Fiorani said:

Advertisement

“China, Australia, and India are supplied by the factory in China, which will not supply vehicles to the U.S. Production of the Model Y L is expected to begin in the U.S. in September, which will lead to sales beginning before the end of 2026.”

Production would take place at Gigafactory Texas.

Additionally, a few Model Y L units have been spotted under wraps in the United States, giving more indication that Tesla plans to bring the vehicle to the U.S. When Tesla is close to launching a vehicle in the U.S., it is not uncommon to see these models with the exact car covers that you see below:

It makes sense, especially considering Musk hinted the Model Y L would make it to the U.S. in late 2026, but it was up in the air. The CEO said the advent of self-driving might not warrant a larger SUV coming to the U.S. market specifically.

The problem is, consumers do not want to hear that. They love Tesla’s tech, FSD, and other features, but they need more space for growing families. The Model X is gone, and the most anyone can fit in a Tesla right now is seven people in the seven-seat Model Y. That back row is truly only large enough to fit small children comfortably.

Tesla fans have requested a full-size SUV, and the company has made some hints that it could be in the plans.

Advertisement

The Model Y and Model Y L differ noticeably in size, with the Model Y L being a stretched, six-seat variant designed for great interior room. The Standard Model Y measures approximately 4,790mm in length, 1,982 mm in width with the mirrors folded, 1,624mm in height, and 2,890mm in wheel base.

In contrast, the Model Y L extends to be about 4,969–4,976mm long (roughly 179mm or 7 inches longer), stands 1,668mm tall (+44mm), and features a significantly longer 3,040 mm wheelbase (+150mm), while maintaining the same width.

This elongation primarily benefits rear passenger space and enables a 2+2+2 seating layout with captain’s chairs, though it slightly reduces maximum cargo capacity behind the rearmost seats and adds a bit of overall mass and turning radius. The result is a more spacious family hauler that still shares the core footprint and agile character of the original Model Y.

Advertisement
Continue Reading

News

One of Tesla’s biggest threats just got banned in the U.S.

Published

on

In a major development that will inevitably strengthen Tesla’s dominant position in the American EV market, Polestar has been effectively banned from selling new vehicles in the United States, starting with the 2027 model year.

The U.S. Department of Commerce denied Polestar authorization under the Connected Vehicle Rule, which prohibits vehicles containing certain connected technologies (Cellular, Wi-Fi, Bluetooth, etc.) linked to China or Russia due to national security risks, including potential data collection on American drivers.

Polestar, which is majority-owned by China’s Geely Holding, could not obtain the required exemption despite producing some models domestically.

Polestar confirmed it will sell off any remaining inventory of the Polestar 3 and Polestar 4 models, while continuing service and warranty support for existing customers. No new models or major refreshes will reach U.S. buyers, and the company is pivoting its growth strategy to Europe, where it already generates the vast majority of its sales.

Advertisement

The outcome removes a direct premium EV competitor that had positioned itself as a stylish, performance-oriented alternative to Tesla’s lineup. The Polestar 2 challenged the Model 3, while the Polestar 3 and 4 targeted segments overlapping with the Model Y and upcoming Tesla offerings. Polestar’s U.S. sales had already been sluggish amid intense competition and slower demand, representing just 6 percent of its global volume in the first quarter of 2026.

While Polestar was not on Tesla’s level in the U.S., it still places a dent in the evergrowing field of Tesla competitors in the country, where it has long dominated EV sales.

Tesla faces none of these hurdles. As a U.S.-founded and U.S.-headquartered company with major manufacturing in Fremont, Austin, and Nevada, Tesla’s vehicles are built with compliant domestic and allied supply chains. Its Full Self-Driving technology, over-the-air software updates, and vertically integrated ecosystem were developed entirely in-house without foreign ownership entanglements that trigger national security reviews, at least in the U.S.

Of course, it did face a similar threat in China a few years back:

Advertisement

Elon Musk responds to reports of Tesla ban among China’s military over security concerns

The Connected Vehicle Rule, first advanced under the prior administration and upheld under the current one, is part of a broader U.S. effort to protect the domestic auto industry and critical technology from Chinese influence. High tariffs on Chinese-made EVs and related restrictions have already reshaped the market. Tesla benefits directly: it avoids these barriers while continuing to lead in U.S. EV sales volume, Supercharger network expansion, and energy storage integration.

By clearing Polestar from the new-vehicle playing field, the policy reduces competitive pressure in the premium and performance EV segments where Tesla has invested billions. American consumers seeking cutting-edge electric vehicles now have one fewer option tied to foreign adversaries — and one clearer path to the market leader that has driven the EV transition from the start.

For Tesla, this is more than regulatory relief. It is a strategic tailwind that reinforces its position as America’s premier EV innovator at a time when domestic manufacturing and technological independence matter most.

Advertisement
Continue Reading

News

Tesla Cybercab stands to gain from new Trump autonomy rules

Published

on

Credit: Teslarati

Tesla Cybercab stands to gain from new rules that the Trump Administration is aiming to enforce on autonomous vehicles. On Thursday, NHTSA, under the Trump Administration’s U.S. Department of Transportation, commenced rulemaking on the Federal Motor Vehicle Safety Standards (FMVSS).

This effort aims to eliminate the mandate for manual brake pedals in vehicles that are designed to be driven exclusively by automated driving systems. This would impact the Tesla Cybercab, which the company has stated would operate without a steering wheel or pedals.

Tesla Cybercab launch is imminent after latest sighting at Giga Texas

The Trump Administration is looking to revise FMVSS No. 135, which requires standard braking systems on light-duty vehicles.

Advertisement

Currently, the regulation requires light-duty cars to use traditional manual braking systems that allow operators to slow the vehicle. With the advent of self-driving in the U.S., these regulations need updating, and these are the changes that could come to FMVSS No. 135:

  • Removes requirements for hand- or foot-operated brake controls for vehicles designed never to be operated by a human. Existing rules still apply to AVs that retain manual controls.
  • All subject vehicles must still meet the same stopping distance performance criteria via alternative testing procedures.
  • While this update ensures AVs can physically stop when commanded, NHTSA is separately developing safety performance requirements for AVs in real-world driving scenarios.
  • NHTSA will continue to use its broad defect enforcement authority to investigate unsafe ADS behavior and oversee recalls.

As autonomy becomes a greater part of passenger travel, these types of rule adjustments will be more than reasonable. It will give manufacturers the ability to self-certify their vehicles and avoid any red tape that could ultimately delay the deployment of these vehicles.

Administrators are also incredibly excited about the opportunity to play a role in the advancement of self-driving vehicles.

“We are at the cusp of the greatest technological revolution in vehicle technology since the innovation of the Model T,” NHTSA Administrator Jonathan Morrison said. “If we want America to lead the way, we have to reimagine our regulatory framework. That’s why under Secretary Sean Duffy’s AV Framework, NHTSA is tearing down pointless barriers to innovative designs while strengthening the fundamental safety requirements that matter and holding AV developers accountable for safe performance.”

The Cybercab entered mass production at Gigafactory Texas in April. Tesla ultimately plans to push the vehicle into its Robotaxi fleet, potentially when frameworks like these are established.

Advertisement
Continue Reading